Stablecoin Evolution: Why Deloitte and NovaBay Are Betting on Stablecorp’s QCAD NovaBay Pharmaceuticals’ stock surged 18% after the company announced it is shifting away from its biotech operations and rebranding as “Stablecoin Development Corporation” (SDEV). The rebranding will take effect on April 3, 2026, marking a complete pivot to the cryptocurrency sector. The move comes with $134 million in funding from major investors including Tether and Framework Ventures, which will support SDEV’s focus on stablecoins. The company already holds over 2.06 billion SKY tokens and plans to leverage them for returns through blockchain protocols. Michael Kazley, CEO of SDEV, emphasized the strategy, stating, “We are building the premier public market vehicle to access cash flows within the growing stablecoin economy.” Meanwhile, in Canada, Deloitte Canada has partnered with Stablecorp to develop financial systems using QCAD stablecoins. This collaboration aligns with new legislation like Bill C-15, which signals stablecoins are becoming integrated into the formal financial system rather than remaining a niche crypto concept. Soumak Chatterjee, a Deloitte partner, highlighted the potential, noting, “Stablecoins present a significant opportunity for Canada’s payments landscape.” The partnership aims to create a compliant framework for banks to adopt stablecoins like QCAD, enabling faster transactions, reduced costs, and avoidance of traditional T+2 settlement delays. Kesem Frank, CEO of Stablecorp, added, “Working with Deloitte Canada is a major opportunity to unlock QCAD’s benefits for all.” The stablecoin market is expanding rapidly, with Visa on-chain analytics reporting total stablecoin transactions reaching $69.9 trillion.#novaBay_pharmaceuticals #stablecorp #deloitte_canada #qcad_stablecoin #framework_ventures
